Business Description
Autonomix Medical Inc
NAICS : 339112
SIC : 3845
ISIN : US05330T2050
Total Employee Number:
11Description
Autonomix Medical Inc is a development-stage medical device company focused on advancing technologies for sensing and treating disorders of the nervous system. Its platform is designed to integrate high-sensitivity neural signal detection with targeted radiofrequency (RF) ablation, enabling a sense, treat, verify approach for nerve-targeted therapies. The Company operates in one reportable segment, which is advancing the development of technologies for sensing and treating disorders relating to the nervous system. It is initially focused on developing the technology for patients with pancreatic cancer and believes the technology has the potential to address several indications, including chronic pain management, hypertension, cardiovascular disease, and other nerve-related disorders.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Equity-to-Asset | 0.78 | |||||
Interest Coverage | No Debt | |||||
Piotroski F-Score | 2/9 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | -6.9 | |||||
3-Year EPS without NRI Growth Rate | -7.2 | |||||
3-Year FCF Growth Rate | 1.2 | |||||
3-Year Book Growth Rate | -5.5 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 27.63 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 25.73 | |||||
9-Day RSI | 31.98 | |||||
14-Day RSI | 35.34 | |||||
3-1 Month Momentum % | 1.66 | |||||
6-1 Month Momentum % | -22.88 | |||||
12-1 Month Momentum % | -73.03 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 4.45 | |||||
Quick Ratio | 4.45 | |||||
Cash Ratio | 4.11 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -121.5 | |||||
Shareholder Yield % | -98.96 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
ROE % | -231.95 | |||||
ROA % | -187.62 | |||||
ROIC % | -5629.54 | |||||
ROC (Joel Greenblatt) % | -87973.68 | |||||
ROCE % | -231.95 | |||||
Moat Score | 2 | |||||
Tariff Resilience Score | 5 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PB Ratio | 0.53 | |||||
Price-to-Tangible-Book | 0.53 | |||||
EV-to-EBIT | 0.45 | |||||
EV-to-EBITDA | 0.45 | |||||
EV-to-FCF | 0.62 | |||||
| Price-to-Net-Current-Asset-Value | 0.53 | |||||
| Price-to-Net-Cash | 0.59 | |||||
Earnings Yield (Greenblatt) % | 222.22 | |||||
FCF Yield % | -393.15 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:AMIX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Autonomix Medical Inc Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -63.917 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | 62.93 | ||
| 14-Day RSI | 35.34 | ||
| 14-Day ATR ($) | 0.614321 | ||
| 20-Day SMA ($) | 6.96983 | ||
| 12-1 Month Momentum % | -73.03 | ||
| 52-Week Range ($) | 4.2042 - 55.4379 | ||
| Shares Outstanding (Mil) | 0.54 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Autonomix Medical Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Autonomix Medical Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Second quarter earnings results for 2027 | 2026-11-12 | In 121 days | ||
| First quarter earnings results for 2027 | 2026-08-13 | In 30 days | ||
| General meeting for 2026 | 2026-07-31 | In 17 days | ||
| 0.047619:1 Stock Split | 2026-06-24 | 7.54 (-5.48%) | ||
| Fourth quarter earnings results for 2026 | 2026-05-29 | 8.72 (+4.96%) | ||
| Annual report for 2026 | 2026-05-27 | 8.78 (+6.63%) | ||
| Third quarter earnings results for 2026 | 2026-02-11 | 8.72 (+1.22%) | ||
| Second quarter earnings results for 2026 | 2025-11-12 | 17.83 (-1.42%) | ||
| H.C. Wainwright 27th Annual Global Investment Conference | 2025-09-05 07:00 | 22.58 (-6.52%) | ||
| Virtual Investor Webinar Hosted by Ladenburg Thalmann & Co. Inc. | 2025-08-21 13:00 | 22.05 (-1.87%) |
Show
Entries
Autonomix Medical Inc Frequently Asked Questions
What is Autonomix Medical Inc(AMIX)'s stock price today?
The current price of AMIX is $5.77. The 52 week high of AMIX is $55.44 and 52 week low is $4.20.
When is next earnings date of Autonomix Medical Inc(AMIX)?
The next earnings date of Autonomix Medical Inc(AMIX) is 2026-08-13 Est..
Does Autonomix Medical Inc(AMIX) pay dividends? If so, how much?
Autonomix Medical Inc(AMIX) does not pay dividend.
Guru Commentaries on NAS:AMIX
No articles.
Press Release
| Subject | Date | ||
|---|---|---|---|
| Autonomix Medical Inc. Covered in Benzinga Article Highlighting Innovative Nerve Treatment Technology | 2024-04-16 |
Articles on Autonomix Medical Inc
Headlines
See More- 1
Jun 18, 2026
Autonomix Medical announces 1-for-21 reverse stock split
Seeking Alpha • 3:52pm
- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers